Manic episode

F5_MANIA

bipolar disorder: A disorder of the brain that causes unusual shifts in mood, energy, activity levels and the ability to carry out day-to-day tasks. Often these moods range and shift from periods of elation and energized behavior to those of hopelessness and depression.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — F30 Cause of death: ICD-10 — F30 2 out of 7 registries used, show all original rules.	1218
4. Check minimum number of events None	1218
5. Include endpoints None	1218
6. Filter based on genotype QC (FinnGen only)	1218

Control definitions (FinnGen only)

Control exclude: F5_MOOD

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: F30-F39
Name in latin: Mania

NAME	F5_MANIA
CONTROL_EXCLUDE	F5_MOOD
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	F30
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	F30
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Manic episode based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	8563	4317	4191
Only index persons	7736	3974	3762
Unadjusted period prevalence (%)
Whole population	0.12	0.12	0.12
Only index persons	0.14	0.15	0.14
Median age at first event (years)
Whole population	47.10	47.61	46.64
Only index persons	45.55	45.98	45.08

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1218	676	542
Unadjusted period prevalence (%)	0.23	0.23	0.24
Median age at first event (years)	43.84	41.85	46.32

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1122: Matched controls
11220

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

4227.0

323.0

452

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

4394.9

323.0

330

N05AX12

ATC

aripiprazole; systemic

95.5

323.0

428

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

167.3

323.0

814

174

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

1553.9

323.0

512

F30.9

ICD-10 Finland

Manic episode, unspecified

+∞

323.0

399

F30.0

ICD-10 Finland

Hypomania

+∞

323.0

307

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

+∞

323.0

365

N05AN01

ATC

lithium; oral

319.0

323.0

456

N03AG01

ATC

valproic acid; systemic, rectal

77.9

323.0

623

177

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

+∞

323.0

353

N05AH04

ATC

quetiapine; oral

51.8

323.0

819

557

N05AX08

ATC

risperidone; systemic

35.0

323.0

440

203

N05AH03

ATC

olanzapine; systemic

138.7

323.0

676

121

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

+∞

319.5

291

F29

ICD-10 Finland

Unspecified nonorganic psychosis

56.7

317.0

374

F30.20

ICD-10 Finland

Mania with mood-congruent psychotic symptoms

+∞

303.3

277

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

+∞

290.6

266

N03AX09

ATC

lamotrigine; oral

53.0

286.0

342

N05AA02

ATC

levomepromazine; systemic

48.0

246.7

301

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

2581.6

238.2

222

F31.8

ICD-10 Finland

Other bipolar affective disorders

1371.9

235.0

221

F30.1

ICD-10 Finland

Mania without psychotic symptoms

+∞

229.2

212

F31

ICD-10 Finland

Bipolar affective disorder

2449.1

228.1

213

N05BA04

ATC

oxazepam; oral

8.1

191.9

535

1138

P99

ICPC

Psychological disorders other

48.7

191.7

233

F32.9

ICD-10 Finland

Depressive episode, unspecified

20.3

188.4

294

193

N05AF03

ATC

chlorprothixene; systemic

49.2

161.6

196

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

11.7

153.3

307

350

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

62.6

150.7

175

N06AB04

ATC

citalopram; systemic

6.9

144.9

430

924

N05BA06

ATC

lorazepam; systemic, sublingual

24.4

144.8

210

105

N05AB03

ATC

perphenazine; systemic, rectal

30.5

142.3

193

T36

ICD-10 Finland

Poisoning by systemic antibiotics

26.7

139.3

196

N05CD07

ATC

temazepam; oral

10.1

135.1

293

380

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

73.6

135.0

153

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

+∞

133.0

125

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

87.9

132.1

146

P29

ICPC

Psychological sympt/compl other

12.6

130.0

247

246

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

70.8

129.9

148

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

52.3

125.1

150

N04AA02

ATC

biperiden; systemic

36.6

122.3

158

ZY010

NOMESCO Finland

Hospital outpatient

17.4

122.1

199

137

N05AD01

ATC

haloperidol; systemic

26.7

120.3

169

N05CF01

ATC

zopiclone; oral

4.9

119.5

515

1652

N06AB06

ATC

sertraline; oral

9.2

114.3

259

354

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

93.7

113.8

125

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

106.1

113.6

123

F39

ICD-10 Finland

Unspecified mood [affective] disorder

164.6

113.6

118

N05BA01

ATC

diazepam; systemic, rectal

7.3

111.7

302

542

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

30.2

110.7

150

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

110.8

110.4

119

N06AX11

ATC

mirtazapine; oral

4.6

108.7

493

1627

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

20.1

106.0

163

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

10.9

104.9

213

236

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

+∞

102.7

F31.2

ICD-10 Finland

Bipolar affective disorder, current episode manic with psychotic symptoms

+∞

102.7

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

110.7

102.0

110

IGY02

NOMESCO Finland

Psychiatric monitoring contact

49.2

101.5

123

ZY000

NOMESCO Finland

Hospital inpatient

65.1

101.3

117

N06AX16

ATC

venlafaxine; oral

7.0

96.0

262

467

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

67.6

95.8

110

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

49.2

94.9

115

N05AA01

ATC

chlorpromazine; systemic, rectal

35.3

94.6

123

IGY99

NOMESCO Finland

Other psychiatric treatment contact

60.2

93.2

109

N07BB01

ATC

disulfiram; oral

13.5

92.0

166

142

N06AB03

ATC

fluoxetine; oral

7.1

91.7

247

430

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

+∞

86.6

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

193.1

86.5

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

10.1

86.1

181

210

Z2446

NOMESCO Finland

Social worker

9.3

85.6

189

239

F31.21

ICD-10 Finland

Bipolar disorder, manic episode with mood incongruent psychotic symptoms

+∞

85.5

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

90.0

82.4

SPAT1240

SPAT

Therapeutic discussion

5.7

82.3

266

580

N05AH02

ATC

clozapine; systemic

21.4

82.2

123

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

7.2

82.2

217

363

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

11.5

82.1

160

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

75.0

79.6

N05AC02

ATC

thioridazine; oral

22.5

78.9

116

P73

ICPC

Affective psychosis

415.5

78.9

N06AX12

ATC

bupropion; oral

12.6

78.5

146

132

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

789.6

76.2

N05AF05

ATC

zuclopenthixol; systemic

34.5

72.8

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

104.7

71.9

N06AB10

ATC

escitalopram; oral

4.2

70.6

322

990

F30.2

ICD-10 Finland

Mania with psychotic symptoms

+∞

70.6

C07AA05

ATC

propranolol; systemic

4.0

70.2

339

1097

F61.0

ICD-10 Finland

Mixed personality disorders

75.9

69.2

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

38.7

67.8

Z2445

NOMESCO Finland

Psychologist

12.4

67.8

126

113

F30.21

ICD-10 Finland

Mania with mood-incongruent psychotic symptoms

+∞

67.4

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

8.2

67.2

159

222

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

80.4

67.0

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

88.0

66.9

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

9.4

66.0

143

172

P72

ICPC

Schizophrenia

19.4

65.5

101

F99

ICD-10 Finland

Mental disorder, not otherwise specified

20.1

64.4

N06AX03

ATC

mianserin; oral

12.8

62.9

115

N05BE01

ATC

buspirone; oral

19.3

62.3

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

169.5

61.6

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

59.0

61.5

F10.20

ICD-10 Finland

Alcohol dependence currently independent

20.7

59.8

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

7.3

59.5

151

233

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

60.2

58.3

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

17.4

58.1

N03AE01

ATC

clonazepam; systemic

8.9

57.9

129

162

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

109.3

57.4

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

5.7

55.7

173

348

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

11.1

55.1

108

107

ZYC01

NOMESCO Finland

Remote contact by phone

8.8

54.7

122

153

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

7.5

54.1

135

202

SPAT1234

SPAT

Support of social functional capacity

9.6

54.0

114

130

F25.01

ICD-10 Finland

Schizoaffective syndrome, manic type with prolonged schizophrenic than bipolar symptoms

79.3

53.6

SPAT1222

SPAT

Counselling/guidance promoting independent living

4.1

53.5

236

684

P76

ICPC

Depressive disorder

8.0

53.2

126

174

F25.0

ICD-10 Finland

Schizoaffective disorder, manic type

188.9

52.4

N05AE04

ATC

ziprasidone; systemic

100.0

52.3

P01

ICPC

Feeling anxious/nervous/tense

4.3

51.2

213

583

N03AF01

ATC

carbamazepine; oral, rectal

7.6

50.6

124

180

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

5.4

50.1

163

344

F60.9

ICD-10 Finland

Personality disorder, unspecified

45.9

50.0

P98

ICPC

Psychosis NOS/other

47.8

48.7

AA400

NOMESCO Finland

Electroconvulsive therapy

133.4

48.2

AA1AD

NOMESCO Finland

CT of head and brain

3.2

48.2

299

1132

N06AB05

ATC

paroxetine; oral

7.3

47.4

119

179

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

90.8

47.2

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

8.7

47.1

105

131

SPAT1254

SPAT

Administration of medicine

3.7

46.8

230

726

188

Kela drug reimbursment

Psychosis requiring demanding treatment

23.3

45.8

F51.0

ICD-10 Finland

Nonorganic insomnia

3.8

45.7

220

681

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

17.8

45.6

P03

ICPC

Feeling depressed

4.8

45.4

165

392

P27

ICPC

Fear of mental disorder

35.2

44.2

F20.9

ICD-10 Finland

Schizophrenia, unspecified

13.4

44.1

F10.25

ICD-10 Finland

Alcohol dependence continuous use

19.7

44.1

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

14.0

43.2

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

53.3

43.0

SPAT1243

SPAT

Psychiatric/psychological examination

10.1

42.3

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

30.9

42.1

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

11.7

41.9

N05BA12

ATC

alprazolam; oral

4.6

41.4

155

378

IGV01

NOMESCO Finland

Psychiatric network contact

69.9

41.4

F41.1

ICD-10 Finland

Generalized anxiety disorder

7.7

40.9

137

Z3231

NOMESCO Finland

Registered nurse

2.7

40.6

351

1621

N05AH05

ATC

asenapine; oral

411.7

40.4

F23.90

ICD-10 Finland

Acute and transient psychosis, unspecified without acute stress factor

68.4

40.4

2962C

ICD-9 Finland

Affective psychoses, Major depressive disorder, single episode[PSYCHOSIS BIPOLARIS MANICA,KESKIVAIKEA]

+∞

39.8

F25.21

ICD-10 Finland

Schizoaffective syndrome, mixed type with prolonged schizophrenic than bipolar symptoms

207.1

39.1

2962E

ICD-9 Finland

Affective psychoses, Major depressive disorder, single episode[PSYCH.BIPOLARIS MANICA,VAIKEA-ASTE,PSYKOOT PIIRTEIT]

+∞

38.8

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

58.5

38.6

SPAT1307

SPAT

Psychosocial counselling and guidance

4.8

37.3

133

307

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

17.2

37.1

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

13.5

37.0

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

33.4

36.9

F30.8

ICD-10 Finland

Other manic episodes

+∞

36.7

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

+∞

36.7

IEY01

NOMESCO Finland

Psychoeducation, individual

83.0

36.0

A06AD11

ATC

lactulose; oral

3.6

35.5

179

567

R41.0

ICD-10 Finland

Disorientation, unspecified

10.4

35.2

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

69.0

35.2

ZXY60

NOMESCO Finland

2-person team, nurses

185.7

34.9

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

16.3

34.6

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

+∞

34.6

N05AX13

ATC

paliperidone; systemic

37.2

33.9

N06AX26

ATC

vortioxetine; oral

6.7

33.9

142

P15

ICPC

Chronic alcohol abuse

8.9

33.6

N05CF02

ATC

zolpidem; oral

2.9

33.2

226

886

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

3.4

33.0

174

569

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

76.6

33.0

F10.24

ICD-10 Finland

Alcohol depence active use

18.4

33.0

N05AL01

ATC

sulpiride; systemic

20.4

32.9

2957A

ICD-9 Finland

Schizophrenic psychoses, Schizo-affective type

120.3

32.8

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.7

32.7

261

1129

F34.1

ICD-10 Finland

Dysthymia

17.7

32.6

EBA00

NOMESCO Finland

Extraction of tooth

2.2

32.0

429

2428

F22.0

ICD-10 Finland

Delusional disorder

21.3

32.0

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

4.0

31.6

135

370

ZXY01

NOMESCO Finland

Chief Physician, Head of Department or Deputy Chief Physician

54.6

31.5

N06AA12

ATC

doxepin; systemic

7.1

31.3

119

IGY02

SPAT

43.6

31.0

F23.99

ICD-10 Finland

Acute and transient psychosis, unspecified UNS

72.0

31.0

IBZ02

NOMESCO Finland

Somatic assessment of psychiatric patient

321.4

31.0

N06AX05

ATC

trazodone; oral

16.3

31.0

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

30.3

30.9

ZXY49

NOMESCO Finland

Other health care provider

47.7

30.7

N06AG02

ATC

moclobemide; oral

7.3

30.5

109

P28

ICPC

Limited function/disability (P)

33.6

30.1

N05AE05

ATC

lurasidone; oral

310.4

29.9

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

14.9

29.9

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

109.7

29.8

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

46.4

29.8

F21

ICD-10 Finland

Schizotypal disorder

46.4

29.8

F05.9

ICD-10 Finland

Delirium, unspecified

14.6

29.1

IGP01

NOMESCO Finland

Psychiatric family contact

67.8

29.0

P74

ICPC

Anxiety disorder/anxiety state

6.3

28.6

131

R53

ICD-10 Finland

Malaise and fatigue

2.6

28.4

247

1113

P80

ICPC

Personality disorder

56.6

28.3

P06

ICPC

Sleep disturbance

3.4

28.3

150

491

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

11.1

28.2

29610

ICD-8 Finland

Affective psychoses, Manic-depression psychosis, manic type

+∞

28.2

H03AA01

ATC

levothyroxine sodium; systemic

2.5

28.2

267

1258

K02.1

ICD-10 Finland

Caries of dentine

2.0

27.9

693

4983

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

102.7

27.8

ZYD01

NOMESCO Finland

Emergency clinic

148.7

27.8

N05AD03

ATC

melperone; systemic

18.9

27.6

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

5.2

27.5

180

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

12.1

27.4

A04

ICPC

Weakness/tiredness general

3.0

27.3

169

617

A28

ICPC

Limited function/disability NOS

3.3

27.2

150

504

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

4.4

27.1

104

257

F12.1

ICD-10 Finland

Mental and behavioural disorders due to use of cannabinoids, harmful use

63.7

27.1

L17

ICPC

Foot/toe symptom/complaint

2.3

26.8

289

1453

N06AX21

ATC

duloxetine; oral

3.6

26.7

127

381

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

23.9

26.2

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

2.4

26.2

262

1265

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

16.1

26.0

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

7.0

26.0

F25.2

ICD-10 Finland

Schizoaffective disorder, mixed type

138.2

25.7

SPAT1301

SPAT

No procedures

2.1

25.7

359

2023

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

45.4

25.6

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

9.5

25.2

F10.09

ICD-10 Finland

Alcohol intoxication UNS

9.1

25.0

N05AB01

ATC

dixyrazine; systemic

24.0

24.9

SAA01

NOMESCO Finland

Simple examination of mouth

2.0

24.8

820

6433

F25.11

ICD-10 Finland

Schizoaffective syndrome, depressive type with prolonged schizophrenic than bipolar symptoms

255.5

24.8

IEY08

NOMESCO Finland

Psychiatric coaching, domestic and community skills

92.2

24.7

F23.3

ICD-10 Finland

Other acute predominantly delusional psychotic disorders

35.4

24.4

R60.0

ICD-10 Finland

Localized oedema

3.3

24.2

131

434

2962D

ICD-9 Finland

Affective psychoses, Major depressive disorder, single episode[PSYCHOSIS BIPOLARIS MANICA,VAIKEA-ASTEINEN]

+∞

24.0

IER01

NOMESCO Finland

Psychoeducation, group

38.5

24.0

ZYB04

NOMESCO Finland

Outreach service in patient’s home or everyday environment

69.0

23.9

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.8

23.9

172

689

F32.1

ICD-10 Finland

Moderate depressive episode

5.5

23.8

138

F25

ICD-10 Finland

Schizoaffective disorders

127.7

23.7

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

6.0

23.4

116

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

3.4

23.4

118

370

Z71.8

ICD-10 Finland

Other specified counselling

2.2

23.3

297

1596

K59.09

ICD-10 Finland

Constipation, unspecified

4.5

23.3

200

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

2.0

23.2

363

2129

ICC03

NOMESCO Finland

Psychiatric treatment plan, transfer to psychiatric ward

55.2

23.1

F25.1

ICD-10 Finland

Schizoaffective disorder, depressive type

66.4

22.9

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

16.9

22.8

2988A

ICD-9 Finland

Other nonorganic psychoses, Other and unspecified reactive psychosis

85.2

22.7

IEY21

NOMESCO Finland

Other intensified psychiatric treatment

234.6

22.7

IFA99

NOMESCO Finland

Other psychiatric pharmacotherapy service

28.0

22.3

N06AB08

ATC

fluvoxamine; oral

8.1

22.2

RS220

NOMESCO Finland

11.5

22.0

2962A

ICD-9 Finland

Affective psychoses, Major depressive disorder, single episode[PSYCHOSIS BIPOLARIS MANICA NUD]

+∞

21.9

P19

ICPC

Drug abuse

14.1

21.9

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

44.3

21.5

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

17.9

21.4

SPAT1216

SPAT

Assessment of functional ability

2.7

21.3

154

617

R56.8

ICD-10 Finland

Other and unspecified convulsions

4.0

21.2

234

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

34.5

21.2

WX110

NOMESCO Finland

Local anesthesy

1.9

21.1

778

6125

N06CA01

ATC

amitriptyline and psycholeptics; systemic

3.4

21.1

108

342

D12

ICPC

Constipation

6.9

21.1

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.8

21.0

621

4532

X78

ICD-10 Finland

Intentional self-harm by sharp object

28.7

21.0

F50.9

ICD-10 Finland

Eating disorder, unspecified

22.0

20.9

F06.30

ICD-10 Finland

Organic manic syndrome

213.8

20.6

F25.80

ICD-10 Finland

Other specified schizoaffective disorder with only concomitant bipolar and schizophrenic symptoms

213.8

20.6

ZYY01

NOMESCO Finland

Contact between professionals

112.1

20.6

F40.1

ICD-10 Finland

Social phobias

8.9

20.2

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.8

20.2

555

3931

T90

ICPC

Diabetes non-insulin dependent

2.2

20.1

222

1111

N05BA02

ATC

chlordiazepoxide; systemic

7.2

20.1

N06AA09

ATC

amitriptyline; systemic

3.2

20.0

109

362

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.0

19.9

309

1784

2967A

ICD-9 Finland

Affective psychoses, Bipolar affective disorder, unspecified

+∞

19.8

R25.1

ICD-10 Finland

Tremor, unspecified

6.8

19.8

N05AF01

ATC

flupentixol; systemic

11.2

19.8

S06.0

ICD-10 Finland

Concussion

2.8

19.8

137

532

Z2221

NOMESCO Finland

Medical doctor

2.0

19.7

309

1791

G21.1

ICD-10 Finland

Other drug-induced secondary parkinsonism

106.9

19.6

F28

ICD-10 Finland

Other nonorganic psychotic disorders

56.0

19.0

29630

ICD-8 Finland

Affective psychoses, Manic-depressive psychosis, circular type

+∞

18.8

30041

ICD-8 Finland

Neuroses, Depressiva

+∞

18.8

ZXY82

NOMESCO Finland

Nurse in multidisciplinary team

71.1

18.8

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

3.4

18.7

288

L28

ICPC

Limited function/disability (L)

2.6

18.7

144

594

SPAT1310

SPAT

Counselling related to known health issue

1.9

18.6

351

2174

29570

ICD-8 Finland

Schizophrenia, Schizo-affective type

101.8

18.6

IAB11

NOMESCO Finland

Psychiatric mood consultation

193.1

18.6

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

10.9

18.5

F32.8

ICD-10 Finland

Other depressive episodes

30.6

18.4

F43.1

ICD-10 Finland

Post-traumatic stress disorder

7.5

18.3

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.8

18.3

616

4599

N05CD02

ATC

nitrazepam; oral

11.3

18.3

-1

NOMESCO Finland

1.8

18.3

413

2718

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

3.8

18.2

224

B18.2

ICD-10 Finland

Chronic viral hepatitis C

10.0

18.2

T74.1

ICD-10 Finland

Physical abuse

6.4

18.2

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

18.1

409

2689

SAA02

NOMESCO Finland

Basic examination of mouth

1.8

18.1

739

5846

29999

ICD-8 Finland

Unspecified psychosis

20.4

17.8

F23.8

ICD-10 Finland

Other acute and transient psychotic disorders

67.7

17.8

N06BA04

ATC

methylphenidate; oral

6.5

17.8

2961C

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]

+∞

17.8

F60.8

ICD-10 Finland

Other specific personality disorders

96.6

17.6

EBA05

NOMESCO Finland

Complicated extraction of tooth

2.1

17.6

228

1217

ZXY80

NOMESCO Finland

Doctor in multidisciplinary team

182.7

17.6

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

15.9

17.5

WX290

NOMESCO Finland

Other blockade of nerve

1.7

17.3

537

3886

W0A12

NOMESCO Finland

Planned therapy visit for psychiatric disease

42.7

17.3

N06AX22

ATC

agomelatine; oral

9.5

17.2

N06AA06

ATC

trimipramine; systemic

7.5

17.1

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3009466) Valproate [Moles/volume] in Serum or Plasma

423

102.34

307.65

8.1

5.7

umol/l

409.4

365.4

1.76

387

(3028707) Methadone [Presence] in Urine by Screen method

200

110

21.56

256.29

4.6

3.6

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

508

1163

6.78

228.76

2.8

1.7

1.6

1.4

8.51

466

1035

(3011288) Drugs identified in Urine by Screen method

218

263

9.88

172.64

5.9

2.6

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

225

347

7.73

144.29

4.3

2.0

—

(3019309) Folate [Moles/volume] in Red Blood Cells

409

1142

4.89

138.59

1.9

1.7

nmol/l

1157.4

1199.2

0.37

343

875

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

698

3009

4.09

128.83

4.1

3.3

u/l

29.6

32.2

1.27

663

2876

(3016879) Cocaine [Presence] in Urine

237

447

6.34

124.48

4.4

1.9

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

630

2588

3.97

123.48

3.0

3.4

mmol/l

2.4

1.69

578

2306

(4198724)

31.64

121.98

3.8

2.0

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

795

3873

4.03

119.81

7.1

6.5

mmol/l

1.2

9.21

668

3276

(3000764) Benzodiazepines [Presence] in Urine

241

490

5.88

116.62

4.6

1.8

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

736

3461

3.85

115.67

6.3

5.8

mmol/l

1.2

8.60

687

3155

(3028300) Cannabinoids [Presence] in Urine

240

498

5.76

113.45

4.7

1.8

—

(3018418) pH of Serum or Plasma

564

2251

3.80

113.25

4.1

3.9

7.4

0.44

104

447

(3027008) Opiates [Presence] in Urine

238

496

5.72

111.90

4.6

1.8

—

(3027944) Amphetamines [Presence] in Urine

231

493

5.55

105.48

4.7

1.7

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1058

7208

4.56

79.10

6.7

3.6

pmol/l

14.5

14.6

1.00

1012

6613

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

613

3052

3.03

78.37

2.3

1.8

pmol/l

95.3

96.3

0.21

352

1609

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1025

6861

4.12

78.00

8.3

7.2

u/l

75.2

75.8

0.18

984

6478

(3021960) Folate [Moles/volume] in Serum or Plasma

418

1678

3.27

77.92

1.7

1.5

nmol/l

18.9

21.0

2.14

381

1448

(3024561) Albumin [Mass/volume] in Serum or Plasma

652

3421

2.95

74.67

4.7

4.8

g/l

35.7

36.3

1.81

616

3187

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

19.88

73.13

3.2

1.8

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

538

2664

2.83

66.81

2.8

2.4

u/l

53.9

57.5

1.54

492

2488

(3006315) Basophils [#/volume] in Blood

759

4637

2.69

59.85

7.8

5.8

e9/l

0.0

0.25

665

4076

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

482

2371

2.71

59.05

2.8

2.0

u/l

289.6

255.8

0.25

463

2242

(3001604) Monocytes [#/volume] in Blood

755

4624

2.66

58.84

7.8

5.8

e9/l

0.6

2.73

663

4056

(3013115) Eosinophils [#/volume] in Blood

773

4810

2.66

57.95

9.1

6.0

e9/l

0.2

0.10

692

4275

(3013650) Neutrophils [#/volume] in Blood by Automated count

830

5351

2.73

57.81

16.2

8.7

e9/l

4.3

3.9

4.27

739

4722

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

732

4468

2.60

56.60

6.1

umol/l

8.9

11.6

16.97

683

4252

(3019198) Lymphocytes [#/volume] in Blood

761

4803

2.56

53.68

8.0

5.8

e9/l

2.0

0.41

671

4299

(42870588) Differential panel, method unspecified - Blood

556

3042

2.52

53.38

6.6

5.9

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

958

6798

2.92

52.54

6.0

2.8

u/l

48.6

43.8

0.65

912

6457

(3013826) Glucose [Moles/volume] in Serum or Plasma

787

5080

2.55

52.34

5.6

4.4

mmol/l

6.7

6.6

0.47

726

4697

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

353

1573

2.75

51.43

1.8

1.6

pmol/l

446.8

32018297.3

1.74

314

1343

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

313

1310

2.87

51.40

2.7

2.9

mmol/l

2.5

2.4

2.94

272

1150

(3009508) Creatinine [Moles/volume] in Urine

481

2516

2.51

50.16

3.9

3.2

mmol/l

6.7

8.2

8.06

423

2155

(3006504) Eosinophils/100 leukocytes in Blood

706

4389

2.45

50.14

7.8

5.9

2.7

2.9

1.13

669

4110

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1113

8706

4.23

49.70

8.5

4.2

mu/l

1.9

2.1

0.67

1074

8067

(3020191) Ethanol [Moles/volume] in Serum or Plasma

10.25

49.24

1.6

1.5

promille

0.8

1.2

1.01

(3019069) Monocytes/100 leukocytes in Blood

706

4419

2.42

48.93

8.1

6.1

8.3

8.5

1.26

672

4175

(3022096) Basophils/100 leukocytes in Blood

681

4249

2.37

46.77

7.9

6.0

0.6

0.7

2.42

645

3993

(3019150) Specific gravity of Urine by Refractometry

385

1874

2.54

46.15

4.3

3.4

kg/l

1.0

1.51

289

(3018010) Neutrophils/100 leukocytes in Blood

708

4534

2.34

45.17

7.9

5.7

57.0

56.5

0.50

667

4291

(3026782) Osmolality of Urine

337

1562

2.60

44.54

3.1

2.5

mosm/kgh2o

459.6

562.5

12.51

283

1343

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

282

1208

2.74

43.56

2.1

1.7

—

(3002030) Lymphocytes/100 leukocytes in Blood

708

4603

2.29

42.62

7.9

5.9

28.4

28.8

0.41

667

4334

(40758558) Short blood count panel - Blood

419

2190

2.39

42.35

9.6

6.5

—

(3023368) Bacteria identified in Blood by Culture

404

2083

2.41

42.07

4.7

4.0

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

16.10

41.86

3.3

1.5

umol/l

130.4

63.1

0.80

(44816559) Phosphatidylethanol [Mass/volume] in Blood

172

5.30

41.21

1.5

1.3

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

583

3567

2.22

39.86

2.5

2.2

nmol/l

71.0

75.8

4.02

551

3258

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

76.16

39.17

1.7

3.5

umol/l

15.5

18.9

—

(3044889) 12 lead EKG panel

859

6208

2.30

37.94

4.3

3.3

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

205

815

2.82

36.04

2.0

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

206

823

2.81

35.87

2.1

1.7

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

1150

9708

4.31

34.86

24.3

12.3

mmol/l

139.2

139.7

5.41

1134

9446

(3026008) Bacteria identified in Urine by Culture

419

2342

2.20

34.83

3.4

2.6

—

(3031040) Bacteria [#/volume] in Urine by Automated count

824

5971

2.17

34.42

5.7

3.7

e6/l

1780.8

2680.7

0.21

(3003458) Phosphate [Moles/volume] in Serum or Plasma

230

999

2.61

33.84

4.3

5.7

mmol/l

1.0

0.20

220

932

(3021589) Normoblasts [#/volume] in Blood

626

4126

2.06

33.27

11.9

8.6

e9/l

0.0

0.01

513

3399

(3002032) Base excess in Venous blood by calculation

165

610

2.97

33.01

2.9

3.5

mmol/l

1.8

0.03

131

492

(3023103) Potassium [Moles/volume] in Serum or Plasma

1148

9749

4.09

32.97

24.1

12.3

mmol/l

4.0

0.53

1133

9468

(3012095) Magnesium [Moles/volume] in Serum or Plasma

269

1272

2.43

32.95

3.7

3.4

mmol/l

0.8

0.12

248

1200

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1106

9190

3.21

32.85

6.1

3.8

mmol/l

6.0

5.8

5.44

1042

8481

(3003181) Sodium [Moles/volume] in Urine

6.05

32.02

1.4

1.3

mmol/l

56.9

63.7

0.59

(3037467) Urinalysis macro (dipstick) panel - Urine

859

6424

2.14

31.67

5.2

3.8

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

362

1990

2.17

30.72

2.1

2.0

mg/l

2.7

2.9

0.32

315

1708

(3021387) Prolactin [Units/volume] in Serum or Plasma

127

433

3.16

29.14

2.0

1.6

mu/l

554.6

280.7

4.93

108

390

(3002582) Erythrocytes [#/volume] in Urine

419

2497

2.03

28.25

3.7

2.8

e6/l

26.7

90.0

1.43

325

1893

(3013707) Erythrocyte sedimentation rate by Westergren method

883

6804

2.08

28.20

4.2

3.8

mm/h

11.1

10.4

0.76

825

6353

(3023183) Ammonium ion [Moles/volume] in Plasma

151

4.56

26.93

2.3

3.4

umol/l

31.4

36.2

1.24

130

(3018095) Leukocytes [#/volume] in Urine

480

3044

1.95

26.76

4.2

3.2

e6/l

46.5

99.2

1.74

339

2075

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

183

792

2.54

26.74

2.5

u/l

28.6

39.1

1.14

153

681

(3036481) Cortisol [Moles/volume] in Serum or Plasma

179

778

2.52

25.88

2.2

2.1

nmol/l

366.0

374.1

0.21

163

721

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

143

556

2.78

25.85

3.3

3.9

ng/l

85.6

78.7

0.25

129

500

(3000850) Epithelial cells [#/volume] in Urine

307

1680

2.11

25.72

3.1

2.3

e6/l

7.1

5.9

0.71

265

1479

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

140

544

2.78

25.32

2.6

3.5

pmol/l

4.3

4.7

3.48

115

492

(36304419) Bacteria [Presence] in Urine

376

2259

1.96

24.06

3.5

2.7

—

(3008295) Osmolality of Serum or Plasma

5.58

23.97

1.6

1.4

mosm/kgh2o

287.0

280.6

0.71

(3030467) Casts [#/volume] in Urine by Automated count

377

2281

1.95

23.54

3.6

2.8

e6/l

0.3

0.4

0.93

281

1700

(3000991) Gas panel - Venous blood

142

579

2.64

23.33

7.1

9.5

—

(3023511) Choriogonadotropin [Units/volume] in Urine

243

3.50

22.76

1.6

1.3

—

(3027945) Reticulocytes/100 erythrocytes in Blood

167

765

2.37

21.35

2.3

2.8

1.9

1.7

1.24

149

694

(3017143) Hepatitis C virus Ab [Presence] in Serum

248

1338

2.07

21.14

1.7

1.6

—

(3020779) Urea [Moles/volume] in Serum or Plasma

149

664

2.42

20.22

5.6

7.7

mmol/l

8.1

8.8

0.57

143

639

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

238

3.34

19.96

2.2

ug/l

864.2

495.8

0.36

221

(3003396) Base excess in Arterial blood by calculation

173

828

2.27

19.91

7.3

8.6

mmol/l

2.1

1.1

2.84

134

665

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

333

2.94

19.49

2.7

3.5

mmol/l

23.9

24.2

0.34

302

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1115

9844

2.57

19.48

19.2

11.3

mg/l

21.4

22.6

0.54

954

7555

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

179

3.66

19.20

1.2

1.4

e6/l

276.3

539.3

0.24

146

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

179

3.66

19.20

1.1

1.4

e6/l

71.7

10.7

0.55

142

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

455

3072

1.77

19.18

4.0

3.1

ng/l

67.9

35.9

0.35

313

1859

(3014576) Chloride [Moles/volume] in Serum or Plasma

180

889

2.20

19.16

7.5

7.7

mmol/l

103.5

104.5

1.43

174

869

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

106

416

2.70

18.70

1.7

1.5

—

(3035350) Ketones [Presence] in Urine by Test strip

622

4616

1.71

18.45

4.1

3.1

estimate

0.0

0.50

129

866

(46235355) HIV 1 and 2 tests - Meaningful Use set

379

2452

1.79

18.32

2.4

1.9

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

153

722

2.28

18.15

2.3

2.2

g/l

0.2

0.22

139

686

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

262

1528

1.91

17.57

2.4

2.0

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1004

8603

1.95

17.41

6.4

4.8

mmol/mol

38.9

39.0

0.12

942

8072

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

189

987

2.08

17.35

2.7

umol/l

8.5

8.6

0.02

145

872

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

31.97

17.06

4.6

6.4

—

(21494755) Public health laboratory ask at order entry panel

1427

0.28

17.01

1.2

1.3

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

7.63

17.00

1.0

ng/l

51.7

44.2

0.11

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

7.63

17.00

1.0

ng/l

740.9

635.2

0.34

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

7.63

17.00

1.0

ng/l

208.7

310.8

1.09

(3032080) INR in Blood by Coagulation assay

460

3197

1.71

16.99

8.5

7.8

inr

1.1

1.2

1.43

155

979

(3027801) Oxygen [Partial pressure] in Arterial blood

166

833

2.15

16.89

7.5

8.5

kpa

11.8

12.7

1.16

161

797

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

166

833

2.15

16.89

7.5

8.5

kpa

5.4

5.1

2.01

159

796

(3002385) Erythrocyte distribution width [Ratio]

986

8425

1.89

16.88

27.0

13.7

13.5

2.36

973

8238

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

138

644

2.29

16.77

4.3

3.5

mmol/l

1.2

1.10

120

557

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

109

461

2.50

16.50

1.6

1.4

—

(3007853) Bacteria identified in Skin by Aerobe culture

187

995

2.04

16.26

1.8

1.5

—

(3009261) Glucose [Presence] in Urine by Test strip

617

4674

1.65

16.09

4.2

3.1

estimate

0.0

0.80

129

851

(3016502) Oxygen saturation in Arterial blood

150

737

2.18

16.07

7.9

9.1

95.3

95.9

0.80

145

711

(3029937) Albumin [Presence] in Urine by Test strip

364

2402

1.74

16.05

4.6

3.4

estimate

0.0

1.08

129

870

(3023520) Reticulocytes [#/volume] in Blood

123

557

2.34

16.01

1.8

2.9

e9/l

79.3

69.7

1.48

429

(3017509) Phencyclidine [Presence] in Urine

13.79

15.94

3.4

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

276

1690

1.82

15.69

2.6

2.1

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

248

1477

1.85

15.39

4.3

3.3

ng/l

157.7

614.2

2.86

172

1053

(3022948) Iron [Moles/volume] in Serum or Plasma

213

1209

1.92

15.33

2.1

2.3

umol/l

12.8

13.9

1.52

196

1121

(3011397) Hemoglobin [Presence] in Urine by Test strip

313

2007

1.75

15.15

3.9

3.1

—

(3044290) Cell count panel - Cerebral spinal fluid

165

3.38

14.77

1.2

1.4

—

(3021901) Oxygen saturation in Capillary blood

132

3.66

14.60

2.8

2.2

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

101

440

2.41

14.33

8.6

7.7

mmol/l

26.1

24.5

2.67

407

(3021601) Nitrite [Presence] in Urine by Test strip

604

4639

1.60

14.25

5.4

4.3

estimate

0.0

0.00

132

894

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

125

3.70

14.20

2.2

1.5

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

197

1118

1.91

14.12

2.1

2.3

g/l

2.4

0.52

175

1040

(40767503) Oxygen content in Capillary blood by calculation

155

3.39

14.07

3.5

2.3

17.1

17.0

0.04

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1148

10526

2.58

14.00

14.3

9.0

u/l

28.4

27.6

0.55

1130

10206

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

4.94

13.84

2.0

1.4

—

(3019977) pH of Arterial blood

6.88

13.61

2.8

2.3

7.3

7.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

227

1363

1.82

13.58

2.7

2.5

e6/l

1.0

0.00

113

773

(3015235) Bicarbonate [Moles/volume] in Capillary blood

197

3.04

13.35

3.7

2.2

mmol/l

25.4

25.0

0.30

174

(3033658) Prothrombin time (PT) actual/Normal

326

2191

1.67

12.99

4.7

3.6

94.8

92.7

0.84

318

2137

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

353

2.48

12.88

2.1

1.7

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

4.63

12.87

1.1

1.7

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

111

528

2.21

12.83

1.7

1.6

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

214

1286

1.81

12.71

2.9

2.6

e6/l

4.3

2.5

0.84

104

696

(1761868) Lipid panel - Serum or Plasma

282

4085

0.60

12.67

3.2

2.5

—

(3012516) Albumin [Mass/volume] in Urine

333

2272

1.64

12.43

3.2

3.3

mg/l

651.0

284.4

0.51

209

1488

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

179

1025

1.87

12.40

2.1

2.3

21.5

24.5

2.02

139

884

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

345

2379

1.63

12.33

1.7

1.6

mmol/l

1.8

1.4

7.01

300

2039

(3010421) pH of Blood

203

2.90

12.09

6.3

3.7

7.4

0.20

168

(3052851) Hemolysis interference index of Serum or Plasma

218

2.79

11.71

3.8

3.3

—

(3012501) Base excess in Blood by calculation

170

3.02

11.52

6.8

3.8

mmol/l

2.7

2.3

0.52

108

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

106

518

2.15

11.45

2.3

u/l

7798.9

4620.3

0.28

217

(3019060) Gas panel - Arterial blood

469

2.18

11.16

4.9

5.4

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1036

9303

1.76

11.11

4.3

3.5

mmol/l

1.5

1.3

11.34

955

8716

(1616796) Gas panel - Central venous blood

175

2.94

10.96

5.7

3.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

148

832

1.89

10.80

5.4

2.9

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

17.99

10.74

1.3

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

360

2.31

10.56

1.4

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1232

0.39

10.54

1.4

1.7

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1077

9820

1.84

10.45

5.3

4.2

mmol/l

2.7

2.9

10.46

1003

9192

(3020682) Albumin/Creatinine [Ratio] in Urine

337

2391

1.57

10.40

4.1

4.0

mg/mmol

10.1

8.7

0.15

206

1560

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

298

2066

1.59

10.13

2.0

1.7

mg/l

1.1

1.0

0.39

227

1524

(3023410) Appearance of Cerebral spinal fluid

3.82

10.08

1.2

1.3

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

289

1995

1.59

9.99

2.5

3.0

ng/l

1116.1

1065.0

0.10

237

1673

(3042936) Bacteria identified in Isolate by Culture

193

1203

1.72

9.96

2.2

1.9

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

158

930

1.80

9.94

2.4

1.8

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

153

900

1.80

9.64

1.6

1.5

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

105

547

2.01

9.57

2.8

2.9

ng/l

149.2

165.5

0.14

484

(3020891) Body temperature

248

2.49

9.57

7.9

5.0

—

(3047181) Lactate [Moles/volume] in Blood

242

2.51

9.57

4.6

6.8

mmol/l

1.3

1.2

0.13

214

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

111

591

1.97

9.51

2.4

2.2

ug/l

11.0

7.9

0.32

521

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1061

9696

1.73

9.36

4.9

3.9

mmol/l

4.5

4.7

10.70

995

9142

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

130

737

1.86

9.22

1.3

1.2

iu/ml

85.3

143.6

1.52

300

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

450

2.08

9.18

3.3

3.0

mmol/l

1.8

1.9

0.14

317

(3009343) pH of Capillary blood

472

2.05

9.11

3.3

3.0

7.4

0.39

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

128

726

1.85

9.07

2.2

1.7

—

(3016018) Differential panel - Cerebral spinal fluid

3.70

9.03

1.1

1.3

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

4.53

8.85

1.0

1.1

—

(3020630) Protein [Mass/volume] in Serum or Plasma

107

580

1.93

8.71

1.8

3.1

g/l

66.1

67.3

0.67

537

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

5.37

8.70

1.1

1.6

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1054

9661

1.68

8.61

4.8

3.8

mmol/l

1.3

1.5

17.64

986

9067

(3001122) Ferritin [Mass/volume] in Serum or Plasma

526

4220

1.43

8.46

3.0

2.6

ug/l

104.3

109.9

0.34

477

3958

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

6.91

8.45

2.6

2.7

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

6.91

8.45

2.6

2.7

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

192

2.56

8.23

2.0

1.7

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

146

2.80

8.18

1.3

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

146

2.80

8.18

1.3

1.2

—

(3022217) INR in Platelet poor plasma by Coagulation assay

143

866

1.74

8.13

16.5

19.9

inr

1.2

0.26

119

(3000494) Fungus identified in Specimen by Culture

167

1060

1.67

7.99

1.7

1.4

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

460

3633

1.43

7.93

4.5

3.2

—

(3006653) Thiamine [Moles/volume] in Blood

4.91

7.90

1.1

1.3

nmol/l

150.4

148.8

0.04

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

306

2241

1.49

7.83

1.3

1.2

u/ml

1.9

1.6

0.18

612

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

414

2.02

7.81

9.6

11.0

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1387

0.50

7.73

1.2

1.4

—

(3019225) pH of Specimen

125

739

1.77

7.73

4.9

4.0

—

(44806118)

3.18

7.72

1.9

1.7

—

(44790048)

3.18

7.72

1.9

1.7

—

(44790047)

3.18

7.72

1.9

1.7

—

(44790049)

3.18

7.72

1.9

1.7

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1003

9151

1.54

7.60

18.4

10.2

ml/min/173m2

90.5

87.3

4.05

815

7457

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

827

0.38

7.37

1.4

—

(3013512) EKG study

307

2286

1.46

7.14

4.4

3.3

—

(40761511) CBC panel - Blood by Automated count

1117

10495

1.78

7.13

18.8

10.6

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

4.41

6.97

1.1

—

(36660697) Celiac disease serology panel - Serum

126

770

1.71

6.93

1.1

1.2

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

138

867

1.67

6.85

3.2

4.6

u/l

209.1

246.8

2.89

133

822

(3003327) Ova and parasites identified in Stool by Light microscopy

323

2.07

6.79

1.7

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

393

1.97

6.77

9.2

11.2

mmol/l

24.5

0.03

371

(3024928) Oxygen saturation in Venous blood

156

2.55

6.73

1.9

2.8

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

273

2008

1.46

6.72

1.8

1.7

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

304

2.10

6.71

1.8

2.2

g/l

1.4

0.14

268

(3007164) IgA [Mass/volume] in Serum or Plasma

268

1966

1.47

6.68

1.5

g/l

2.3

0.25

135

1274

(3016650) Hepatitis A virus Ab [Presence] in Serum

173

2.42

6.34

1.1

—

(3014007) Fractional oxyhemoglobin in Arterial blood

447

1.87

6.29

11.4

11.1

93.3

94.2

0.84

447

(3043409) Potassium [Moles/volume] in Arterial blood

201

2.29

6.14

6.7

4.7

mmol/l

3.9

0.19

187

(3004588) Protein electrophoresis panel - Serum or Plasma

475

1.83

6.04

1.6

2.6

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

5.26

6.01

1.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

192

2.28

5.88

2.2

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

3.32

5.87

1.2

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

3.32

5.87

1.2

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

3.32

5.87

1.2

1.6

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

5.04

5.75

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

2.97

5.59

1.4

1.7

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

4.28

5.56

1.0

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

689

0.42

5.48

1.6

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

3.37

5.45

1.0

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

226

2.12

5.40

3.0

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

138

920

1.56

5.38

10.4

5.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

2.86

5.26

1.2

1.0

—

(3017181) Myelocytes/100 leukocytes in Blood

115

746

1.60

5.05

4.6

4.2

0.6

0.9

1.15

207

(3019832) Treponema pallidum Ab [Presence] in Serum

197

1437

1.44

4.97

1.7

—

(40760892) CBC W Ordered Manual Differential panel - Blood

289

2253

1.37

4.97

7.0

4.3

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

163

2.25

4.82

1.1

1.0

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

230

2.04

4.80

1.1

1.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

9.06

4.79

1.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

138

2.35

4.78

2.4

1.6

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

246

1.99

4.69

1.2

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

246

1.99

4.69

1.2

1.1

—

(40761536) Microorganisms panel - Urine sediment

122

817

1.55

4.68

5.4

3.3

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

347

1.83

4.67

1.3

1.4

u/l

9.1

9.0

0.01

288

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

155

2.23

4.49

1.5

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

279

1.90

4.47

1.9

2.1

ug/l

2.7

2.4

0.05

249

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

2.79

4.46

1.4

1.7

—

(3022621) pH of Urine by Test strip

583

1.63

4.46

2.7

2.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

251

1.95

4.45

1.2

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

218

2.01

4.35

1.4

1.5

ug/g

328.6

287.3

0.64

123

(40761539) Cells [Type] in Urine sediment by Light microscopy

4.57

4.30

1.2

1.0

—

(3035637) Corticotropin [Mass/volume] in Plasma

2.59

4.23

2.3

1.3

—

(3025941) Bacteria identified in Stool by Culture

520

1.64

4.22

1.3

1.2

—

(3002179) Metamyelocytes/100 leukocytes in Blood

103

684

1.55

4.12

4.1

0.6

0.00

156

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

104

2.43

4.07

1.0

1.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

224

1.95

4.05

2.5

1.6

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

291

1.82

3.96

2.0

1.7

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

3.82

3.81

1.1

1.8

—

(3026389) Candida sp identified in Specimen by Organism specific culture

114

2.31

3.80

1.3

1.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

244

1.88

3.79

1.4

1.9

iu/l

5.8

5.3

0.10

(3022313) Gas panel - Capillary blood

334

1.74

3.74

2.5

3.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

4.02

3.70

1.1

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.02

3.70

1.1

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

4.02

3.70

1.1

—

(3007461) Platelets [#/volume] in Blood

1165

11301

1.71

3.65

34.0

16.3

e9/l

256.4

252.2

1.41

1148

11041

(3024731) MCV [Entitic volume]

1166

11314

1.72

3.64

33.7

16.2

91.0

90.4

4.89

1155

11179

(3025159) Blasts/100 leukocytes in Blood

100

680

1.51

3.61

5.2

4.3

0.0

0.6

0.63

164

(3026361) Erythrocytes [#/volume] in Blood

1166

11316

1.71

3.61

33.8

16.3

e12/l

4.5

4.6

5.04

1151

11032

(3021440) Promyelocytes/100 leukocytes in Blood

104

714

1.50

3.59

5.0

4.3

0.1

0.2

1.02

190

(3000093) Morphology [Interpretation] in Blood Narrative

2.67

3.57

1.3

1.1

—

(3010813) Leukocytes [#/volume] in Blood

1166

11320

1.70

3.54

34.0

16.3

e9/l

7.2

6.6

17.50

1150

11035

(3034860) Kappa light chains.free [Mass/volume] in Serum

207

1.91

3.52

1.9

4.1

mg/l

42.3

85.2

0.74

163

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

207

1.91

3.52

1.9

4.1

mg/l

27.9

30.2

0.26

164

(3000963) Hemoglobin [Mass/volume] in Blood

1166

11322

1.70

3.51

34.0

16.4

g/l

135.6

137.6

5.14

1156

11182

(40757373) Influenza virus identified in Isolate

6.19

3.50

2.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

364

1.68

3.49

2.6

2.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

522

1.57

3.49

1.3

iu/l

19.8

25.4

0.89

451

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

107

2.27

3.40

1.0

1.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

269

1.78

3.36

1.3

titre

178.0

80.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

142

2.07

3.28

1.2

1.3

—

(3035941) MCH [Entitic mass]

1164

11315

1.65

3.26

33.6

16.2

30.3

30.2

0.71

1154

11179

(40761535) Cells panel - Urine sediment

633

1.49

3.17

3.5

3.2

—

(40760888) Immunoglobulin light chains.free panel - Serum

166

1.95

3.11

1.7

4.3

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

7.53

3.05

1.3

1.4

ng/l

102.0

88.8

—

(3001556) Androgen free Index in Serum or Plasma

5.03

3.05

1.1

1.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

324

1.66

3.03

2.1

1.8

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

10.03

2.98

1.0

—

(3041096) Erythrocytes [Presence] in Urine by Automated

321

2707

1.25

2.94

3.9

2.8

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

2.85

2.92

1.0

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

347

0.43

2.90

1.5

1.7

—

(3048689) Calprotectin [Mass/mass] in Stool

164

1270

1.34

2.89

2.0

2.5

ug/g

110.9

116.6

0.08

128

1024

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

185

1.86

2.89

1.0

1.2

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

237

1.76

2.88

1.7

2.2

g/l

9.5

10.7

0.76

209

(3037522) Nuclear Ab [Titer] in Serum

167

1304

1.33

2.79

1.5

1.3

titre

610.6

496.2

0.37

281

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

299

0.40

2.78

1.3

1.5

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

124

2.04

2.77

2.0

1.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

131

2.01

2.77

2.6

1.8

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

111

2.09

2.74

2.5

1.7

—

(3045788) Cell count panel - Pleural fluid

2.73

2.72

1.3

—

(3035320) C reactive protein [Mass/volume] in Body fluid

2.44

2.71

2.8

1.9

—

(3039443) Prostate specific Ag panel - Serum or Plasma

230

0.39

2.69

1.2

1.6

—

(3002523) Influenza virus A Ag [Presence] in Specimen

231

0.39

2.69

1.0

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

231

0.39

2.69

1.0

1.1

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

190

1.81

2.68

2.6

4.2

57.1

56.4

0.13

190

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

141

1.94

2.61

3.5

2.9

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

2.15

2.55

1.1

—

(3017569) Oxygen content in Arterial blood

3.05

2.53

2.9

1.7

—

(3024263) Appearance of Synovial fluid

2.84

2.48

1.5

1.9

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

242

1.68

2.43

1.9

2.2

g/l

2.9

3.1

0.51

194

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

204

1.74

2.43

2.0

4.0

ratio

3.4

1.3

—

(3042631) Mycobacterium sp identified in Specimen

103

2.06

2.42

3.2

2.8

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

174

0.34

2.42

1.2

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

258

1.65

2.41

1.9

2.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

258

1.65

2.41

1.9

2.2

g/l

7.3

0.07

200

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

258

1.65

2.41

1.9

2.2

g/l

3.7

3.8

0.02

189

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.96

2.41

1.1

1.0

—

(3044242) Glucose [Moles/volume] in Arterial blood

2.96

2.41

1.8

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

182

1.78

2.41

2.6

3.8

e9/l

4.5

4.1

0.35

182

(3005719) IgG [Mass/volume] in Serum or Plasma

722

1.39

2.40

2.9

2.8

g/l

10.8

10.7

0.11

658

(3006922) Hepatitis E virus Ab [Presence] in Serum

2.36

2.39

1.1

1.0

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

2.43

2.37

1.8

1.6

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

6.27

2.37

1.2

1.4

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

2.27

2.35

1.1

1.2

—

(3036489) Thrombin time

340

1.55

2.33

2.0

1.9

20.6

21.1

0.39

299

(4024509)

2.32

1.7

1.4

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

3.23

2.31

4.2

4.8

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

2.24

2.28

1.1

1.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

4.63

2.27

2.8

2.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

2.21

1.0

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

2.21

2.3

1.4

29.2

39.7

—

(4010399)

571

1.41

2.18

1.5

1.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

151

1.81

2.17

1.2

1.1

iu/ml

43.8

195.5

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

197

1.69

2.14

1.7

2.2

nmol/l

0.8

0.9

0.46

170

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

2.06

2.12

2.0

2.3

33.7

33.2

0.16

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

3.21

2.09

1.0

1.2

—

632.4

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

802

0.68

2.08

1.4

1.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

128

1604

0.77

2.02

2.1

2.7

ug/l

0.7

0.12

934

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

2.65

2.01

1.0

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

2.65

2.01

1.0

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

2.65

2.01

1.0

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

2.65

2.01

1.0

1.7

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

2.83

2.00

1.0

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

2.09

1.97

1.4

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.76

1.93

1.2

1.3

—

(3050129) First trimester maternal screen panel - Serum or Plasma

531

0.63

1.93

1.2

1.4

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

2.13

1.92

1.5

3.1

65.0

52.7

—

(3017732) Neutrophils [#/volume] in Blood

663

1.35

1.92

2.6

e9/l

4.5

4.0

1.01

553

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

145

1172

1.27

1.91

1.7

1.8

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

212

1.62

1.90

3.4

2.8

u/ml

0.3

0.12

109

(3001964) Herpes simplex virus Ag [Presence] in Specimen

3.19

1.88

2.4

1.8

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

151

1.74

1.88

2.2

1.5

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

174

1.68

1.87

1.3

1.4

nmol/l

0.3

0.4

0.52

136

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

100

1.91

1.86

1.2

—

(3013293) Extractable nuclear Ab [Presence] in Serum

3.54

1.84

1.5

1.6

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.51

1.84

1.1

1.3

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

4.18

1.82

1.6

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

199

1.62

1.81

2.0

2.4

ug/min

147.7

102.5

0.25

129

(3028308) Erythrocytes [#/volume] in Pleural fluid

2.28

1.81

1.3

e6/l

97654.5

23818.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.58

1.80

1.1

1.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

146

1.73

1.78

1.8

1.7

—

(4027681)

2.18

1.78

1.2

1.3

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

3.34

1.75

2.5

2.2

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

3.86

1.71

4.0

1.6

mmol/l

1.3

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.86

1.71

1.2

1.1

—

(3001186) Copper [Moles/volume] in Serum or Plasma

3.86

1.71

1.2

umol/l

18.9

18.3

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

382

0.59

1.71

1.3

1.6

—

(3051611) Lipemic interference index of Serum or Plasma

2.01

1.70

5.5

3.9

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

2.11

1.66

1.2

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

2.11

1.66

1.2

1.0

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

577

1.34

1.61

1.2

1.4

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

3.58

1.61

1.0

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

107

1.79

1.55

1.3

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

115

1.75

1.53

1.3

nmol/l

0.6

0.08

109

(3000492) Spirometry study

1044

0.77

1.50

1.7

1.4

—

(3037121) Protein [Mass/volume] in Urine

310

1.44

1.47

2.4

3.7

g/l

0.1

0.2

4.02

134

(3017446) Testosterone [Moles/volume] in Serum or Plasma

784

1.27

1.45

2.8

2.2

nmol/l

11.4

13.5

1.97

712

(4306422)

156

1.62

1.44

1.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

212

1.52

1.44

1.2

1.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

1.98

1.43

1.2

1.1

—

(4268621)

110

1.74

1.43

2.2

2.4

—

(3004809) Band form neutrophils/100 leukocytes in Blood

118

1.71

1.42

3.3

3.2

1.5

1.3

0.18

103

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

2.62

1.37

1.7

1.6

—

(3032057) Clostridioides difficile [Presence] in Stool

2.95

1.36

1.2

1.8

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

167

1.57

1.35

1.2

u/ml

1.8

6.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

1.79

1.33

3.7

3.4

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

152

1.59

1.32

1.0

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

168

1.56

1.32

1.2

1.8

—

(40768800) Prostate Pathology biopsy report

150

0.46

1.31

1.0

1.2

—

(3017704) Immunofixation for Urine

2.10

1.30

1.0

1.7

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

185

1.53

1.30

1.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

106

1.71

1.30

2.3

1.6

—

(3034426) Prothrombin time (PT)

2.36

1.29

1.1

1.5

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

362

1.37

1.28

1.2

u/ml

0.9

1.2

—

(3034770) Mitochondria Ab [Titer] in Serum

277

1.42

1.28

1.3

—

1510.0

—

(3004451) EKG impression Narrative

2.05

1.27

1.0

1.2

—

(40768797) Stomach Pathology biopsy report

137

1159

1.21

1.24

1.3

1.2

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

2.64

1.21

1.2

1.6

g/l

30.6

30.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

101

1.69

1.20

4.2

5.8

mg/l

11.1

10.7

0.14

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

1.84

1.19

1.8

2.5

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

241

2151

1.15

2.0

2.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

564

1.27

1.15

1.1

1.2

—

(21494434) Karyotype in Bone marrow

1.85

1.13

1.1

1.3

—

(4035726)

729

0.77

1.13

1.3

1.4

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

200

1.46

1.13

1.2

1.4

u/ml

94.6

124.3

—

(3028026) IgM [Mass/volume] in Serum or Plasma

575

1.27

1.12

1.9

g/l

1.8

1.4

0.41

530

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

444

1.30

1.08

1.4

1.3

miu/ml

140.7

223.9

0.79

233

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

1.69

1.08

3.9

1.9

—

(4146454)

1.76

1.07

3.2

2.7

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

184

1620

1.16

1.07

1.3

1.2

iu/ml

20.9

28.8

0.87

519

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

105

1.63

1.06

3.4

1.7

—

(3023419) Bacteria identified in Sputum by Culture

105

1.63

1.06

2.8

2.6

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

465

1.28

1.04

1.7

1.8

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

163

1.48

1.02

1.2

u/ml

4.3

4.0

0.04

(3010838) Calcium [Moles/time] in 24 hour Urine

1.88

1.00

1.1

1.6

—

11.2

—

(40768793) Breast Pathology biopsy report

213

0.61

1.00

1.1

1.2

—

(3033799) Differential panel - Peritoneal fluid

2.18

0.98

1.2

2.3

—

(3037556) Urate [Mass/volume] in Serum or Plasma

0.00

0.97

0.0

1.3

—

(4094501)

235

0.63

0.96

1.0

1.1

—

(3051651) Icteric interference index of Serum or Plasma

1.86

0.96

7.3

4.3

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

120

1030

1.18

0.96

5.3

3.9

29.7

31.8

1.34

729

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

1.75

0.96

2.3

u/field

1.4

2.3

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

570

1.24

0.96

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.23

0.93

1.2

2.4

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

142

1.49

0.92

2.2

1.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

167

1.45

0.92

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

235

1.37

0.92

1.5

1.4

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.15

0.91

2.7

1.6

—

(3044007) Cell count panel - Peritoneal fluid

2.07

0.89

1.2

2.4

—

(3044941) Cell count panel - Synovial fluid

144

1.47

0.87

1.3

1.5

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.87

0.87

1.5

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

192

0.62

0.86

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

204

1.38

0.85

1.6

1.8

e6/l

4796.1

12208.9

1.71

158

(3045142) Bone marrow Pathology biopsy report

1.60

0.84

1.1

1.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

129

1.48

0.83

1.6

1.7

—

(3044640) Blood type and Crossmatch panel - Blood

306

2831

1.11

0.83

2.2

2.1

—

(3009542) Hematocrit [Volume Fraction] of Blood

980

9580

1.12

0.82

25.6

11.7

39.8

40.6

2.14

655

7561

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

429

0.76

0.79

1.3

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

429

0.76

0.79

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

429

0.76

0.79

1.3

1.4

—

(3014271) Vancomycin [Susceptibility]

1.82

0.79

3.7

2.3

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

428

0.76

0.78

1.3

1.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

1.77

0.76

1.2

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

1.77

0.76

1.3

1.9

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.77

0.76

3.7

2.6

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

288

1.29

0.76

2.5

2.0

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

1.70

0.76

3.7

1.9

—

(3037756) Immunofixation for Serum or Plasma

149

1.42

0.76

1.2

1.9

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

171

1540

1.13

0.75

1.3

1.2

u/ml

3.4

10.4

3.79

648

(3049717) Cytology report of Urine Cyto stain

263

1.30

0.73

2.2

2.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.80

0.72

1.0

2.3

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.80

0.72

1.0

2.3

—

(3003434) Protein [Mass/volume] in Pleural fluid

1.62

0.71

1.3

1.4

g/l

38.6

35.2

0.57

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.86

0.68

1.0

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

1.60

0.68

1.6

1.4

—

71.2

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

1.79

0.66

1.0

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

103

1.46

0.65

1.3

nmol/l

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

767

7450

1.08

0.64

3.5

3.3

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

1.52

0.62

1.3

e6/l

288461.7

130428.5

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

121

1.41

0.62

1.5

1.3

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

1.46

0.61

1.2

1.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.67

0.61

1.0

1.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.67

0.61

1.0

1.8

—

(4034850)

289

1.25

0.61

9.1

7.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

271

1.26

0.61

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

188

1726

1.11

0.61

1.6

1.5

—

(3025130) Human papilloma virus identified in Specimen

139

1.37

0.60

1.5

1.9

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.00

0.60

0.0

1.0

—

(40758292) HTLV I+II Ab panel - Serum

0.00

0.60

0.0

1.4

—

(3044927) Protein electrophoresis panel - Urine

1.50

0.60

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

283

1.24

0.57

1.3

—

(3003694) ABO and Rh group [Type] in Blood

287

3047

0.92

0.56

1.4

1.5

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.55

1.4

1.1

—

(3045414) Leukocytes [Presence] in Urine

422

1.19

0.55

1.7

1.6

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

197

2122

0.91

0.54

3.3

3.7

23.0

20.9

0.89

893

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

160

1.32

0.53

1.2

1.4

mmol/l

9.4

7.6

0.70

109

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

1.49

0.53

1.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.54

0.53

7.3

3.1

—

(40768446) Kidney Pathology biopsy report

1.54

0.53

1.5

1.4

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.60

0.52

1.3

1.5

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

1.39

0.50

2.3

2.9

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

367

0.81

0.49

1.4

1.7

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

1.52

0.48

1.0

1.1

—

4.6

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

1.45

0.48

1.1

—

(3011412) CD3 cells [#/volume] in Blood

1.42

0.47

2.0

2.4

e9/l

1.1

1.3

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

1.43

0.45

1.4

1.3

g/l

5.2

6.9

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

1.43

0.45

1.4

1.3

g/l

2.4

2.7

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

1.43

0.45

1.4

1.3

g/l

0.2

0.3

—

(40768795) Lymph node Pathology biopsy report

0.59

0.45

1.4

1.2

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

459

0.84

0.44

1.4

1.5

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

458

4417

1.06

0.43

3.9

3.8

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.62

0.43

1.0

1.8

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

218

0.78

0.42

1.0

1.1

u/ml

7.2

7.6

—

122

(3042733) HLA Ab [Presence] in Serum

1.52

0.41

1.6

4.8

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.52

0.41

2.4

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.52

0.41

4.4

1.3

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.00

0.41

0.0

1.3

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.00

0.41

0.0

1.2

—

1.9

—

(3012441) Differential panel - Pleural fluid

1.36

0.41

1.5

1.3

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

1.36

0.41

1.0

2.6

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

0.40

0.0

1.4

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.40

0.0

3.0

—

(3003338) MCHC [Mass/volume]

905

8907

1.06

0.40

31.3

13.6

g/l

332.2

333.6

4.65

899

8838

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

1.34

0.40

3.6

1.7

—

(3036603) Volume of Urine

1.34

0.40

1.3

1.7

—

2000.6

—

(3011648) Oxygen content in Venous blood

1.34

0.40

1.5

1.9

13.4

10.9

—

(3035880) pH of Pleural fluid

1.43

0.39

1.0

1.2

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

345

0.84

0.39

1.4

—

(44813793)

1.35

0.38

1.1

1.0

—

(3005033) Fetal Nuchal fold Thickness US

344

0.84

0.38

1.4

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

216

1.21

0.37

1.6

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

364

0.85

0.36

1.5

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

234

2225

1.06

0.36

1.6

1.5

—

(40768804) Tissue Pathology biopsy report

355

3683

0.95

0.35

2.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

199

1.21

0.35

3.6

4.2

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

1.40

0.35

1.3

1.2

u/l

88.5

76.4

—

(3022145) Colonoscopy Study observation

108

999

1.09

0.34

1.2

1.3

—

(3005322) IgE [Units/volume] in Serum or Plasma

667

0.89

0.34

1.2

1.3

u/ml

304.5

266.7

0.08

620

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

243

0.82

0.34

1.1

u/ml

0.4

1.8

—

100

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

1.32

0.34

1.5

1.4

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

740

1.10

0.33

3.0

4.6

ug/l

17.3

28.0

0.25

596

(3051387) C reactive protein [Mass/volume] in Capillary blood

191

1.21

0.33

4.8

3.4

mg/l

23.8

27.4

0.16

119

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

1.31

0.33

1.2

1.0

iu/ml

245.3

233.3

—

(40768443) Skin Pathology biopsy report

370

1.14

0.32

1.0

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

208

0.81

0.31

1.0

1.1

u/ml

0.5

1.5

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

207

0.82

0.30

1.0

1.1

u/ml

3.8

2.4

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

148

1.22

0.29

1.1

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

109

0.73

0.29

1.6

1.2

—

(40768806) Pleura Pathology biopsy report

1.25

0.27

1.8

1.6

—

(3045424) Erythrocytes [Presence] in Urine

168

1.19

0.27

1.7

1.3

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

352

0.88

0.26

1.4

1.5

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

320

0.87

0.26

2.0

1.6

iu/ml

0.0

0.3

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

1.22

0.25

1.4

1.5

—

(3005570) Glucose [Moles/volume] in Urine

1.25

0.24

1.9

2.1

—

(4062490)

1.28

0.24

1.4

1.3

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

237

1.14

0.23

1.3

1.2

u/ml

7.9

9.6

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.32

0.23

1.2

1.1

—

(3000330) Specific gravity of Urine by Test strip

419

1.10

0.22

3.0

3.1

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

0.77

0.22

2.1

1.4

g/l

1.0

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

1.25

0.22

1.0

1.4

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.25

0.22

1.2

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

1.25

0.22

1.0

1.4

—

(3026493) Urate [Moles/volume] in Serum or Plasma

237

2291

1.04

0.22

2.7

2.5

umol/l

1943.4

5434.3

1.22

202

2044

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

107

1.22

0.21

1.1

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

1.19

0.21

1.4

1.2

u/l

41.0

13.5

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.0

—

(3045462) Protein/Creatinine [Ratio] in Urine

0.00

0.21

0.0

3.3

—

47.5

—

(40762814) Titanium [Mass/volume] in Blood

0.00

0.21

0.0

2.2

—

3.9

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

0.00

0.21

0.0

2.1

—

(3000285) Sodium [Moles/volume] in Blood

0.00

0.21

0.0

1.0

—

(4038314)

0.00

0.21

0.0

1.2

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

0.00

0.21

0.0

4.6

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

0.00

0.21

0.0

4.6

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.0

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.0

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

1.25

0.20

1.0

1.4

—

18.7

—

(3012565) Volume of 24 hour Urine

1.25

0.20

1.5

2.9

2761.7

2018.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

288

1.11

0.20

1.2

1.1

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

241

1.12

0.19

1.1

1.2

—

(4281824)

1.22

0.19

1.1

—

(3002256) Pathology report gross observation

110

1154

0.95

0.19

1.3

1.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

1.13

0.18

8.5

7.4

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

290

0.89

0.18

3.4

3.6

u/ml

18.2

1135.1

1.34

247

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

0.73

0.17

2.0

1.2

—

46.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.16

0.16

1.3

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.16

0.16

1.1

1.0

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

1.13

0.16

1.3

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

1.13

0.16

1.3

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

1.13

0.16

1.3

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

1.11

0.16

1.3

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

1.11

0.16

1.3

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

1.11

0.16

1.3

1.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

235

1.11

0.15

1.3

1.2

u/ml

3.1

2.8

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

219

1.10

0.12

1.3

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

210

1.10

0.12

1.9

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

144

1.11

0.10

2.2

2.6

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

135

1.11

0.09

1.1

1.3

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.06

0.09

1.0

1.1

miu/ml

1945.4

1430.3

—

(1002224) Polysomnography panel

462

0.95

0.09

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

155

0.90

0.09

1.2

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

165

1.09

0.08

1.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

136

1.10

0.08

2.0

1.9

g/l

0.6

1.0

—

102

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

107

1.12

0.08

1.3

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

107

1.12

0.08

1.3

1.4

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.83

0.08

1.4

1.3

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

1.09

0.08

1.1

3.5

u/ml

11.6

77.6

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

372

1.05

0.07

1.7

1.4

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

682

0.97

0.07

2.6

2.4

ml/min/173m2

65.8

72.8

0.58

250

(3005988) Vibrio sp identified in Specimen by Organism specific culture

108

1.11

0.07

1.3

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

108

1.11

0.07

1.3

1.4

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.87

0.07

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.84

0.07

1.9

1.6

—

(3041354) Potassium [Moles/volume] in Venous blood

0.89

0.06

2.0

2.4

mmol/l

4.1

—

(3035285) Chloride [Moles/volume] in Venous blood

0.89

0.06

2.0

2.4

mmol/l

103.3

105.6

—

(3021788) Differential panel - Synovial fluid

158

1.08

0.06

2.3

1.7

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

269

2661

1.01

0.06

3.6

4.2

ug/l

1.7

2.1

1.49

237

2425

(3014133) Dog dander IgE Ab [Units/volume] in Serum

182

0.93

0.05

1.0

u/ml

11.4

3.7

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

110

1.09

0.05

1.3

1.4

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

110

1.09

0.05

2.6

1.7

65.3

55.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

110

1.09

0.05

1.3

1.4

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

160

1.06

0.04

1.4

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

121

1.08

0.03

1.1

1.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

168

0.95

0.02

1.0

1.1

u/ml

3.3

4.9

0.26

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

438

0.98

0.01

1.3

1.7

mg/l

6.8

4.4

0.27

287

(3008898) HLA-B27 [Presence]

413

1.02

0.01

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

396

1.01

0.00

1.1

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

0.94

0.00

4.3

3.7

—

(3013466) aPTT in Blood by Coagulation assay

0.00

0.0

1.0

—

33.3

—

(3025549) Creatine [Moles/time] in 24 hour Urine

0.00

0.0

1.3

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

0.00

0.0

2.8

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

0.00

0.0

1.7

—

(3036525) Urea [Moles/time] in 24 hour Urine

0.00

0.0

2.6

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

0.00

0.0

1.0

—

63.3

—

(3013862) HLA-DP [Type]

0.00

0.0

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.0

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.00

0.00

1.4

1.3

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

394.9

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

0.00

0.0

2.3

—

191.5

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.0

1.0

—

8.7

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(40768441) Liver Pathology biopsy report

0.92

0.00

1.9

1.4

—

(40760409) HLA-A [Type] by High resolution

0.00

0.0

1.0

—

(3020393) Adenovirus Ag [Presence] in Stool

0.00

0.0

1.0

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.01

0.00

1.3

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.00

0.0

3.0

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.00

0.0

1.3

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid

0.00

0.0

5.0

—

17.4

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.00

0.0

1.0

—

(3025315) Body weight

0.00

0.0

1.2

—

(40763590) HLA-DQ beta [Type]

0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

0.92

0.00

2.4

2.5

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

0.85

0.00

1.4

1.3

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.0

1.4

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

0.00

0.0

1.6

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.01

0.00

1.3

1.5

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

5.5

—

(3004775) Volume in Urine collected for unspecified duration

0.92

0.00

2.2

653.3

593.7

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.0

1.0

—

(3016750) Collection duration of Urine

1.00

0.00

1.6

2.3

min

546.8

507.9

—

(3013762) Body weight Measured

0.00

0.0

1.6

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.02

0.00

1.0

1.1

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.0

5.0

—

416.8

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.91

0.00

2.0

2.4

—

(40760410) HLA-B [Type] by High resolution

0.00

0.0

1.0

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.00

0.0

6.4

—

Mortality – FinRegistry

↥

Association

Association between endpoint F5_MANIA and mortality.

Females

Parameter	HR [95% CI]	p-value
F5_MANIA	2.482 [2.14, 2.88]	< 0.001
Birth year	0.991 [0.98, 1.0]	0.039

During the follow-up period (1.1.1998 — 31.12.2019), 843 out of 3677 females with F5_MANIA died.

Males

Parameter	HR [95% CI]	p-value
F5_MANIA	3.049 [2.61, 3.56]	< 0.001
Birth year	0.986 [0.98, 0.99]	0.002

During the follow-up period (1.1.1998 — 31.12.2019), 945 out of 3517 males with F5_MANIA died.

Mortality risk

Mortality risk for people of age

years, who have F5_MANIA.

N-year risk	Females	Males
1	0.167%	0.515%
5	1.046%	3.524%
10	2.924%	8.751%
15	5.769%	16.259%
20	10.569%	25.66%

Relationships between endpoints

↥

Index endpoint: F5_MANIA – Manic episode

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Manic episode

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints